Company news
Decision Diagnostics Corp (OTC:DECN) news
Decision Diagnostics Corp news releases on 6ix. Latest, Mar 20, 2020: DECN to Finance 2Q 2020 Roll Out of its GenViro! Covid-19 "Rapid" Kits Using…
Press releases — page 2
DECN to Finance 2Q 2020 Roll Out of its GenViro! Covid-19 "Rapid" Kits Using Non-Dilutive Debt Financing Totaling $13 Million Acquired in Near 0% Rate Environment
March 19, 2020
DECN's GenViro!(TM) COVID-19 "Rapid" Kit to Reap Huge Boost from 3/16 FDA Guidance Allowing for Near Immediate Distribution of Kits Prior to Emergency Waiver Grant
March 17, 2020
DECN'S GenViro!(TM) Corona Virus "Swift" Kit, Now to Be Additionally Offered to Commercial Labs and Religious Groups as 12 Month Forecast is Raised to 525MM
March 16, 2020
DECN Updates on Its Corona Virus Testing Product Genviro!(TM), With 200,000 Kits to Be Provided in USA & EU Prior to the Summer, 12 Month Forecast Updated to 480mm
March 15, 2020
DECN Provides First Looks At Its GenViro(TM) Corona Virus Screening Kit & First Year Product Forecast of 420 Million Kits, with Sales Beginning Late 3Q 2020
March 10, 2020
DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro(TM) Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology Announced March 2
March 3, 2020
DECN Jumps into Screening and Testing Channel For Coronavirus (COVID19) Using Its Innovative Impedance Technology First Implemented In Its GenUltimate TBG
March 2, 2020
DECN Announces Market Readiness of Its GenUltimate TBG, Adds To Product's Compatibility at The Request Of Strategic Partner, Completes Its Universal Translator GenExpidient! Device
February 19, 2020
DECN Updates on Major 2020 Business Events, Announces New Large Retailer Arrangements, as Company Marches Forward
February 3, 2020
DECN adds to Domestic and International Channels for its GenAccord! Product, Inclusive of the EU and Russian Federation, as Company also Schedules Entry of 2nd GenAccord! Product for Multi-Patient Use
January 20, 2020
DECN to Offer New Bundling for its Products, Starting with Offering a 90-Day Supply of GenUltimate! Test Strips in a Single Box for $38.95
December 16, 2019
DECN in Major Revenue Move Decides to Include New GenAccord! Product Line in its Upcoming Strategic Agreement at the Request of Strategic Partner
December 11, 2019
DECN to Immediately Take Control of Two Market Ready, FDA Cleared, Glucose Monitoring Systems to Augment Its Primary Marketplace Positions
December 9, 2019
DECN Completes Its Genultimate! TBG System Meters, Adding to Final Brilliance After Receiving Development Consultation From Licensors and Big Box
November 6, 2019
DECN Enters Exciting New Phase After High Court Hearing, Long Running Legal Battles With Johnson & Johnson Are Nearing A Positive Ending
October 23, 2019
DECN ENTERS TODAY’S HIGH COURT HEARING WITH A GREAT DEAL OF ANTICIPATION THAT ITS LONG RUNNING LEGAL BATTLES WITH JOHNSON & JOHNSON ARE NEARING AN END
October 2, 2019
DECN Retains Counsel To File For Two Patents Covering GenUltimate TBG Test Strip And System, Consents To The Publication A White Paper By A Biotech Industry Luminary
September 18, 2019
DECN Launches Premier Versions Of Its Successful Genultimate Test Strip, Completes Media Commercial Set To Debut In National Media Markets
September 10, 2019
DECN Adds International Distribution for its Genultimate, Genchoice, Genprecis and Gensure Products
September 3, 2019
After Disclosing the Choice of Licensing Partner Last Week, DECN Receives Two New Accretive Propositions for Its Panacea GenUltimate! TBG
August 7, 2019
DECN Chooses to License its Genultimate TBG Technology to Perfectly Situated Partner, Anticipates Agreement Will Yield Revenue Stream in Excess of $100 Million Over 5 Year Term, Company to Retain its Intellectual Property
July 31, 2019
DECN's Appeal To Be Heard In Case Against J&J Over A Grossly Unfair Ruling And Lower Court's Termination Of The Case Against Their Court Wounded Adversary
July 17, 2019
DECN in Pact with Mega Pet Products Retailer Fetch for Pets Tripling Market For Company's Petsure Test Strips and Genultimate! 4pets Test Strips and Meters
June 24, 2019
DECN Narrows Choices Of Likely Strategic Partners To Two, Serious Talks Begin
June 18, 2019
DECN Discusses Current Financings with Aplha Capital Anstalt, Accepts Latest Proposition from Solicited Party, Will Choose from Two Proposals to Bring Closure
June 12, 2019
DECN Discusses Propositions Received For Its GenUltimate TBG
June 6, 2019
DECN Accepts 4th Unsolicited Proposition for its GenUltimate TGB Product, and Today Launches its GenUltimate TGB Product into Select International Markets
June 5, 2019
DECN to Launch Panacea GenUltimate TBG Diabetic Test Strip and Precise Meter June 6 in Select Off-Shore Markets, with Initial Plan To Target Users And Former Users Of The J&J/Lifescan Meters
May 29, 2019
DECN Discusses Marketplace Intrique Surrounding Its Panacea Product Genultimate TBG, As It Readies June 6 Introduction
May 28, 2019
DECN to Discuss in Detail Three Major Events Just After Memorial Day Holiday
May 22, 2019
DECN Sets Plan to Make Upcoming Patent Infringement Appeal Hearing and Mediation with Johnson & Johnson a Foundation for Substantial Recovery
May 8, 2019
DECN's Appeal Nearing Oral Arguments in its Patent Battle with Johnson & Johnson Over the Unjust Ruling in the Nevada Lower Court
May 6, 2019
In Prelude to Probable Transaction DECN Decides to Infuse its Outre' Precise, TBG Technology to its GenChoice Test Strip, Now in FDA 510k Review
April 22, 2019
DECN Expands Talks Involving Its GenUltimate TBG System, Balances Potential and Competing Outcomes with Recent Intro to 2nd Interested Party
April 16, 2019
DECN Hails Completion of Its Genultimate! TBG Panacea System, 3rd Party Testing to Begin in Next 7 Days, Clinical Trials Testing to Begin in May
April 3, 2019
DECN Launches Its Genultimate 4Pets and Avantage Meter, Ground-Breaking Products for the Testing of Dogs, Cats and Horses, Receives First Retail Orders, Establishes Innovative Rebate Program
March 13, 2019
DECN in Pact with Alpha Capital Anstalt
March 13, 2019
DECN Enters into Strategic Agreement with Paragon Sales and Marketing Inc. for Big Box Sales to Walmart, CVS, Walgreens, Costco and Cardinal Health
March 11, 2019
DECN Subsidiary Receives 510k Submission And ''K'' Numbers from FDA CDRH for Its Genchoice! Test Strip at the Close of the Government Shutdown
January 29, 2019
DECN Discusses Its Panacea GenUltimate! TBG System, Offering Elite Performance And Premier Upgrade Path For 4+ Million Users Of Lifescan Ultra Meters
January 16, 2019
DECN Subsidiaries Appeal Nevada District Court Trial Judge's Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)
December 18, 2018
DECN Engages Second Korean Manufacturing Partner to Raise Its Factory Capacity by Two Million Boxes of ''GEN'' Test Strips Annually
December 16, 2018
DECN Releases its Strategic IP And Product Development Introduction Plan With a Summary of 2018 Achievements and 2019 Expectations
December 10, 2018
DECN Receives Completed Clinical Trials Report from its IRB and Anticipates Filing its U.S. FDA 510k Application for its Genchoice! Product on December 21, 2018
December 3, 2018
DECN CEO Keith M. Berman Is Interviewed By Prestigious Wall Street Reporter Who Describe Company And Products As ''Game Changer''
November 26, 2018
DECN Receives Completed Clinical Trial Data, Charts and Spreadsheets Essential for its Imminent Genchoice! Test Strip
November 5, 2018
DECN Set to Appeal the Clearly Unfair Ruling in Court's Termination of the DECN Patent Infringement and False Advertising Case Battle with Johnson & Johnson
October 29, 2018
DECN Board Of Directors In Final Review Of Preliminary Financing Agreement For $4.75 Million Investment
September 12, 2018
DECN Announces Major Step Ahead with Offering Statement
September 5, 2018
DECN Announces Significant Updates For Products And Programs
August 13, 2018